Humanigen

Humanigen

Pharmaceuticals, 117 High Rock Rd, Burlingame, California, 06482, United States, 11-50 Employees

humanigen.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 65********

Who is HUMANIGEN

Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating ...

Read More

map
  • 117 High Rock Rd, Burlingame, California, 06482, United States Headquarters: 117 High Rock Rd, Burlingame, California, 06482, United States
  • 2001 Date Founded: 2001
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 8731 | NAICS Code: 518210 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from HUMANIGEN

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Humanigen

Answer: Humanigen's headquarters are located at 117 High Rock Rd, Burlingame, California, 06482, United States

Answer: Humanigen's phone number is 65********

Answer: Humanigen's official website is https://humanigen.com

Answer: Humanigen's revenue is $1 Million to $5 Million

Answer: Humanigen's SIC: 8731

Answer: Humanigen's NAICS: 518210

Answer: Humanigen has 11-50 employees

Answer: Humanigen is in Pharmaceuticals

Answer: Humanigen contact info: Phone number: 65******** Website: https://humanigen.com

Answer: Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating cytokine storm via its novel, cutting-edge anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody neutralization and gene-knockout platforms. Its proprietary Humaneered monoclonal antibodies, designed to optimize antibody properties, show promise in prevention/treatment of cytokine storm induced by SARS-CoV-2 (COVID-19), chimeric antigen receptor T-cell (CAR-T) therapy and graft versus host disease (GvHD) by neutralizing GM-CSF which is up-regulated in these conditions.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access